“In addition, we have signed a distribution agreement with Primacyt, a leading provider of primary cells and services for biomedical and cell biology research”, adds Dr. Simon Widmaier, business development manager of faCellitate. ”The BIOFLOATTM 96 well plates are an ideal addition for their cell culture product portfolio. This collaboration will enable us to reach a larger audience and provide a more personalized service for toxicological studies with primary liver cells. These agreements are a major step for faCellitate to strengthen its international distribution network”, summarizes Dr. Widmaier.
faCellitate strengthens its international distribution network
“In addition, we have signed a distribution agreement with Primacyt, a leading provider of primary cells and services for biomedical and cell biology research”, adds Dr. Simon Widmaier, business development manager of faCellitate. ”The BIOFLOATTM 96 well plates are an ideal addition for their cell culture product portfolio. This collaboration will enable us to reach a larger audience and provide a more personalized service for toxicological studies with primary liver cells. These agreements are a major step for faCellitate to strengthen its international distribution network”, summarizes Dr. Widmaier.